artesunate Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Breakthrough Therapy FDA Priority Review FDA

Active Ingredient History

  • Now
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinine for severe malaria. Often it is used as part of combination therapy, such as artesunate plus mefloquine. It is not used for the prevention of malaria. Artesunate can be given by injection into a vein, injection into a muscle, by mouth, and by rectum.   Wikipedia

  • SMILES: C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
  • Mol. Mass: 384.43
  • ALogP: 2.6
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Parenteral
  • Pro Drug: Yes
arinate | arsuamoon | arsumax | artesunate | artesunato | artesunatum | artesunic acid | as | butanedioic acid, 1-[(3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester | cosunate | dihydroartemisinine-12-alpha-succinate | dihydroqinghasu hemsuccinate | malacef | malartin | sm 804 | sm-804 | sodium artesunate | succinyl dihydroartemisinin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue